IL6 and neoplasm: Notably, immune‐related pathway activities, including TNFα signaling, interferon pathways, and IL6‐JAK‐STAT3 signaling, were reduced in stiff tumors, suggesting a diminished immune response potentially from altered structural characteristics of the tumor.